Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL01Antineoplastic agents
- Pharmacological subgroupL01F
- Chemical subgroupL01FD
- Chemical substanceL01FD02Pertuzumab
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Spain
AEMPS · 14 registrations
- Perjeta 420 MG Concentrado Para Solucion Para Perfusion30 mg · concentrado para solución para perfusión · Roche Registration Gmbh · 3 entries
- Perjeta 420 MG Concentrado Para Solucion Para Perfusion30,0 mg · concentrado para solución para perfusión · Roche Registration Gmbh
Canada
Health Canada · 4 registrations
At a glance
- ATC code
- L01FD02
- Registers
- 10
- Historical lists
- 2
- Registrations
- 48
- With their own page
- 41
- Companies
- 12
All medicines with Pertuzumab
Human medicines from every register that match Pertuzumab by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
48 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Perjeta | United States | 420MG/14ML | vial | Marketed | Genentech |
| PhesgoCombination | United States | 1,200MG, 600MG | injectable | Marketed | Genentech INC |
| Poherdy | United States | 420MG/14ML | injectable | Marketed | Shanghai Henlius Biotech |
| Perjeta | European Union | Authorised | Roche Registration GmbH | ||
| Perjeta | Canada | 420 MG / 14 ML | Solution | Marketed | Hoffmann-LA Roche Limited |
| PhesgoCombination | European Union | Authorised | Roche Registration GmbH | ||
| Perjeta 420 MG Concentrado Para Solucion Para Perfusion | Spain | 30,0 mg | concentrado para solución para perfusión | Marketed | Roche Registration Gmbh |
| Perjeta 420 MG Concentrado Para Solucion Para Perfusion | Spain | 30 mg | concentrado para solución para perfusión | Marketed | Roche Registration Gmbh |
| Perjeta 420 MG Concentrado Para Solucion Para Perfusion | Spain | 30,0 mg | concentrado para solución para perfusión | Marketed | Roche Registration Gmbh |
| Perjeta 420 MG Concentrado Para Solucion Para Perfusion | Spain | 30 mg | concentrado para solución para perfusión | Marketed | Roche Registration Gmbh |
| Perjeta 420 MG Concentrado Para Solucion Para Perfusion | Spain | 30 mg | concentrado para solución para perfusión | Marketed | Roche Registration Gmbh |
| Poherdy | European Union | Authorised | Organon N.V. | ||
| Perjeta | Brazil | Authorised | Produtos Roche Químicos e Farmacêuticos S.A. | ||
| Phesgo 600 MG/600 MG Solucion InyectableCombination | Spain | 600 mg + 600 mg | solución inyectable | Marketed | Roche Registration Gmbh |
| Phesgo 600 MG/600 MG Solucion InyectableCombination | Spain | 600 mg + 600 mg | solución inyectable | Marketed | Roche Registration Gmbh |
| Phesgo 1200 MG/600 MG Solucion InyectableCombination | Spain | 1200 mg + 600 mg | solución inyectable | Marketed | Roche Registration Gmbh |
| Phesgo 1200 MG/600 MG Solucion InyectableCombination | Spain | 1200 mg + 600 mg | solución inyectable | Marketed | Roche Registration Gmbh |
| Perjeta® | Serbia | 420mg | koncentrat za rastvor za infuziju | Authorised | Roche DOO Beograd |
| Perjeta-HerceptinCombination | Canada | 420 MG / 14 ML + 440 MG / VIAL | Kit, Powder For Solution, Solution | Marketed | Hoffmann-LA Roche Limited |
| Perjeta 420 MG Concentrado Para Solucion Para Perfusion | Spain | 30 mg | concentrado para solución para perfusión | Authorised | Roche Registration Gmbh |
| Perjeta 420 MG Concentrado Para Solucion Para Perfusion | Spain | 30 mg/ml | concentrado para solución para perfusión | Authorised | Roche Registration Gmbh |
| Poherdy 420 MG Concentrado Para Solucion Para Perfusion | Spain | 420 mg | concentrado para solución para perfusión | Authorised | Organon N.V. |
| Perjeta, 420 mg Concentraat voor oplossing voor infusie | Netherlands | Concentraat voor oplossing voor infusie | Authorised | Roche Registration GmbH | |
| Perjeta | Croatia | Marketed | |||
| Phesgo 600 MG/600 MG Solucion InyectableCombination | Spain | 600 mg + 600 mg | solución inyectable | Authorised | Roche Registration Gmbh |